Voyager Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
90.30 |
37.62 |
69.35 |
62.30 |
65.00 |
76.28 |
| Przychód Δ r/r |
0.00% |
-58.33% |
84.32% |
-10.16% |
4.33% |
17.37% |
| Przychód (min) |
85.71 |
1.69 |
19.81 |
10.64 |
11.10 |
13.03 |
| Przychód (max) |
94.99 |
60.95 |
158.42 |
116.89 |
121.95 |
143.12 |
| EBITDA (średnia) |
-41.43 |
-17.26 |
-31.81 |
-28.58 |
-29.82 |
-35.00 |
| EBIT (średnia) |
-42.47 |
-17.70 |
-32.62 |
-29.31 |
-30.57 |
-35.88 |
| EBIT % |
-47.04% |
-47.04% |
-47.04% |
-47.04% |
-47.04% |
-47.04% |
| Zysk netto (średni) |
-50.07 |
-121.84 |
-108.89 |
-127.31 |
-86.67 |
-80.06 |
| Zysk netto % |
-55.45% |
-323.85% |
-157.02% |
-204.34% |
-133.34% |
-104.95% |
| EPS (średnia) |
-0.92 |
-2.11 |
-1.33 |
-1.61 |
-1.50 |
-1.39 |
| Liczba analityków (Przychody) |
9 |
8 |
11 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
9 |
9 |
11 |
7 |
5 |
2 |
| symbol |
VYGR |
VYGR |
VYGR |
VYGR |
VYGR |
VYGR |